Drug Patents owned by Sovereign Pharms

1. Drug name - OBREDON

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9549907 SOVEREIGN PHARMS Immediate release oral guaifenesin solution
Nov, 2035

(13 years from now)

US9808431 SOVEREIGN PHARMS Immediate release oral guaifenesin solution
Nov, 2035

(13 years from now)

US10105324 SOVEREIGN PHARMS Immediate release oral guaifenesin solution
Nov, 2035

(13 years from now)

More Information on Dosage
Strength Dosage Availability
200MG/5ML;2.5MG/5ML SOLUTION;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.